John Wilson

Associate Professor
Vanderbilt University
Nashville, Tennessee, United States

Disclosure information not submitted.

Presentation(s):

• Immunoengineering I: Nanoparticles for Vaccines

  Thursday, October 24, 2024
  1:15 PM – 2:45 PM EST

• Poster CC18 - Glioblastoma Immunotherapy using RIG-I Activating Nanoparticles

  Thursday, October 24, 2024
  2:45 PM – 3:45 PM EST

• Immunoengineering II: Cell & Molecular Engineering

  Thursday, October 24, 2024
  3:45 PM – 5:15 PM EST

• Alu RNAs show Efficacy as Cancer Vaccine Adjuvants

  Thursday, October 24, 2024
  3:45 PM – 4:00 PM EST

• Immunoengineering III: Immune Tolerance

  Friday, October 25, 2024
  8:30 AM – 10:00 AM EST

• Poster W15 - Intracellular Delivery of Triphosphorylated Stem-loop RNAs for Potent RIG-I Activation and Improved Anticancer Immune Responses

  Friday, October 25, 2024
  10:00 AM – 11:00 AM EST

• Immunoengineering IV: Systems Immunology & Computational Analysis

  Friday, October 25, 2024
  2:00 PM – 3:30 PM EST

• Enabling Technologies for Biomanufacturing Extracellular Vesicle-Based Therapeutics

  Friday, October 25, 2024
  4:30 PM – 5:00 PM EST

• Immunoengineering V: Immune Mechanobiology

  Friday, October 25, 2024
  4:30 PM – 6:00 PM EST

• Albumin-binding nanobody-antigen fusions enhance antigen presentation and improve vaccine responses through pharmacokinetic modulation

  Saturday, October 26, 2024
  9:45 AM – 10:00 AM EST

• Immunoengineering VI: T cell Responses in Cancer Immunotherapy

  Saturday, October 26, 2024
  12:30 PM – 2:00 PM EST